-
1 Comment
Fuan Pharmaceutical (Group) Co., Ltd is currently in a long term downtrend where the price is trading 9.1% below its 200 day moving average.
From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Fuan Pharmaceutical (Group) Co., Ltd's total revenue sank by 18.2% to $548M since the same quarter in the previous year.
Its net income has dropped by 79.4% to $14M since the same quarter in the previous year.
Finally, its free cash flow fell by 215.5% to $-28M since the same quarter in the previous year.
Based on the above factors, Fuan Pharmaceutical (Group) Co., Ltd gets an overall score of 1/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE1000011G4 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 5B |
|---|---|
| PE Ratio | 20.9 |
| Dividend Yield | 1.2% |
| Target Price | None |
| Beta | 0.3 |
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300194.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
